These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 6104957
21. Structure of leukotriene C. Identification of the amino acid part. Hammarström S, Murphy RC, Samuelsson B, Clark DA, Mioskowski C, Corey EJ. Biochem Biophys Res Commun; 1979 Dec 28; 91(4):1266-72. PubMed ID: 43155 [No Abstract] [Full Text] [Related]
22. Leukotriene C4: the major lipoxygenase metabolite of arachidonic acid in dog spleen. Malik KU, Wong PY. Biochem Biophys Res Commun; 1981 Nov 30; 103(2):511-20. PubMed ID: 6800364 [No Abstract] [Full Text] [Related]
23. Enzymatic formation of 14,15-leukotriene A and C(14)-sulfur-linked peptides. Sok DE, Han CO, Shieh WR, Zhou BN, Sih CJ. Biochem Biophys Res Commun; 1982 Feb 26; 104(4):1363-70. PubMed ID: 6280711 [No Abstract] [Full Text] [Related]
24. Slow reacting substance (SRS) from ionophore A23187-stimulated human leukemic basophils. I. Evidence for a precursor role of arachidonic acid and initial purification. Yecies LD, Wedner HJ, Parker CW. J Immunol; 1979 Dec 26; 123(6):2814-6. PubMed ID: 41019 [Abstract] [Full Text] [Related]
25. Purification of arachidonic acid metabolites from cell cultures by octadecyl reversed phase cartridges. Bedetti C, Cantafora A. Dev Biol Stand; 1985 Dec 26; 60():331-6. PubMed ID: 3930318 [Abstract] [Full Text] [Related]
27. Oxidative products of arachidonate: leukotrienes, a new group of compounds, including slow-reacting substance of anaphylaxis (SRA-A). Samuelsson B. Kroc Found Ser; 1981 Dec 26; 14():1-11. PubMed ID: 6118396 [No Abstract] [Full Text] [Related]
28. [Biosynthesis of SRS-A from [1-C14] arachidonic acid]. Fujiwara H. Nippon Ganka Gakkai Zasshi; 1984 Sep 26; 88(9):1255-8. PubMed ID: 6524547 [No Abstract] [Full Text] [Related]
29. Release of slow reacting substance from rabbit ocular tissues. Kin K. Jpn J Ophthalmol; 1984 Sep 26; 28(3):263-73. PubMed ID: 6151994 [Abstract] [Full Text] [Related]
35. [Brain tissue leukotrienes in cerebral ischemia and the effect of inhibitor of SRS-A release on postischemic cerebral edema]. Mabe H, Suzuka T, Nagai H, Nagai H, Koda A. No To Shinkei; 1988 Jul 26; 40(7):673-8. PubMed ID: 2465014 [Abstract] [Full Text] [Related]
36. [Slow reacting substance from human peripheral polymorphonuclear leukocytes by incubation with fresh autologous serum and zymosan. Part 1. Requirement for SRS release from PMNs and comparison of the behavior of synthetic leukotrienes and SRS released from human PMN on HPLC]. Kishimoto M, Katagiri M, Torii S. Arerugi; 1983 Dec 26; 32(12):1180-5. PubMed ID: 6146300 [No Abstract] [Full Text] [Related]
37. Racemic LTA4 methyl ester bioconversion into LTC4 methyl ester by various glutathione S-transferases. Maury G, Ginestar E, Sraïri D, Thaler-Dao H, Dembélé-Duchesne MJ, Lorquin J, Crastes de Paulet A. Biochem Int; 1987 Dec 26; 15(6):1127-35. PubMed ID: 3125835 [Abstract] [Full Text] [Related]
38. Evidence for leukotriene formation and a neuroendocrine role for leukotriene C4 in rat brain. Lindgren JA, Hulting AL, Hökfelt T, Dahlén SE, Eneroth P, Werner S, Patrono C, Samuelsson B. Adv Prostaglandin Thromboxane Leukot Res; 1985 Dec 26; 15():561-4. PubMed ID: 2936169 [No Abstract] [Full Text] [Related]
39. Comparative studies on immunologically and non-immunologically produced slow-reacting substances from man, guinea-pig and rat. Morris HR, Piper PJ, Taylor GW, Tippins JR. Br J Pharmacol; 1979 Oct 26; 67(2):179-84. PubMed ID: 40646 [Abstract] [Full Text] [Related]